empagliflozin glp-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal? Heard all about GLP-1s recently?

Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy

IV glutathione is an effective detoxifier and aid for cell repair and in preventing chemotherapy toxicity

Aurisco Pharmaceutical Co.,Ltd will exhibit at CPhI Frankfurt 28-30.October.2025 read the full article here: #GLP1 #GLP1RA #Cardiovascular #MACE #Generics #obesity #diabetes To view or add a comment, sign in Novo Nordisk (NYSE: $NVO) is acquiring Akero Therapeutics (NASDAQ: $AKRO) in a $4.7B deal, adding efruxifermin (EFX) a late-stage FGF21 analogue for MASH to its growing portfolio

Whether this reflects individual variation, absorption issues with the oral formulation, or quality concerns with specific batches is difficult to determine from reviews alone